Clincosm LogoSign in Get a demo

Primary Peritoneal Cavity Cancer

Showing 51 - 75 of 126
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer Trial in New York (carboplatin, docetaxel)

Unknown status
  • Endometrial Cancer
  • +3 more
  • New York, New York
    Herbert Irving Comprehensive Cancer Center at Columbia Universit
Jan 3, 2014

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in London (carboplatin, cisplatin, paclitaxel)

Completed
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • London, England, United Kingdom
    Middlesex Hospital- Meyerstein Institute
Dec 18, 2013

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Glasgow (carboplatin, docetaxel, paclitaxel)

Completed
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • Glasgow, Scotland, United Kingdom
    C.R.C. Beatson Laboratories
Dec 18, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Los Angeles (CP-547,632)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Dec 18, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Worldwide (chemo)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • Vienna, Austria
  • +20 more
Dec 3, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Canada, United States (irinotecan)

Terminated
  • Fallopian Tube Cancer
  • +2 more
  • Mobile, Alabama
  • +99 more
Nov 7, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Des Moines (herpes simplex thymidine kinase,

Unknown status
  • Fallopian Tube Cancer
  • +2 more
  • Des Moines, Iowa
    Human Gene Therapy Research Institute
Nov 5, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Canada, United States (oregovomab)

Unknown status
  • Fallopian Tube Cancer
  • +2 more
  • oregovomab
  • Berkeley, California
  • +45 more
Nov 5, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Canada, United States (oregovomab)

Unknown status
  • Fallopian Tube Cancer
  • +2 more
  • oregovomab
  • Newport Beach, California
  • +15 more
Nov 5, 2013

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (carboplatin, oglufanide disodium, paclitaxel)

Unknown status
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • Glendale, California
  • +18 more
Nov 5, 2013

Chemotherapy in Ovarian Cancer, Fallopian Tube Cancer, or

Unknown status
  • Fallopian Tube Cancer
  • +2 more
  • flow cytometry
  • immunohistochemistry staining method
  • Atlanta, Georgia
    Southeastern Gynecologic Oncology, LLP - Northside
Sep 19, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Birmingham, Wolverhampton (carboplatin,

Unknown status
  • Fallopian Tube Cancer
  • +2 more
  • Birmingham, England, United Kingdom
  • +3 more
Sep 16, 2013

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in London (yttrium Y 90 mAb HMFG1)

Unknown status
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • yttrium Y 90 monoclonal antibody HMFG1
  • London, England, United Kingdom
    Antisoma
Sep 16, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Worldwide (erlotinib HCl)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • erlotinib hydrochloride
  • Randwick, New South Wales, Australia
  • +91 more
Aug 26, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Innsbruck (gemcitabine HCl,

Unknown status
  • Fallopian Tube Cancer
  • +2 more
  • gemcitabine hydrochloride
  • +2 more
  • Innsbruck, Austria
    Innsbruck Universitaetsklinik
Aug 23, 2013

Breast Cancer, Cervical Cancer, Endometrial Cancer Trial in United Kingdom (genetic, other, radiation)

Unknown status
  • Breast Cancer
  • +9 more
  • gene expression analysis
  • +4 more
  • Brighton, England, United Kingdom
  • +10 more
Aug 23, 2013

Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Duarte (bryostatin 1,

Completed
  • Fallopian Tube Cancer
  • +4 more
  • bryostatin 1
  • +2 more
  • Duarte, California
    City of Hope
Aug 23, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (laparoscopic surgery)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • laparoscopic surgery
  • Los Angeles, California
  • +10 more
Aug 19, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Worldwide (biological, drug, other, procedure)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • bevacizumab
  • +5 more
  • Liverpool, New South Wales, Australia
  • +141 more
Aug 9, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United Kingdom (carboplatin, paclitaxel,

Completed
  • Fallopian Tube Cancer
  • +2 more
  • Aylesbury-Buckinghamshire, England, United Kingdom
  • +69 more
Aug 9, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United Kingdom (tamoxifen citrate, diagnostic

Unknown status
  • Fallopian Tube Cancer
  • +2 more
  • tamoxifen citrate
  • diagnostic laboratory biomarker analysis
  • Burton-upon-Trent, England, United Kingdom
  • +23 more
Aug 9, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Australia, New Zealand, United Kingdom

Completed
  • Fallopian Tube Cancer
  • +2 more
  • Hornsby, New South Wales, Australia
  • +87 more
Aug 6, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Germany, Hungary, Netherlands (carboplatin,

Unknown status
  • Fallopian Tube Cancer
  • +2 more
  • Berlin, Germany
  • +6 more
Aug 6, 2013

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Wilmington (plevitrexed, topotecan HCl)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • Wilmington, Delaware
    AstraZeneca Pharmaceuticals LP
Aug 1, 2013

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Iowa City (celecoxib, paclitaxel)

Terminated
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at University of Iowa
Jul 8, 2013